Biotech startup Kineta inks cancer deal with Pfizer worth up to $505M by James Thorne on December 17, 2018December 17, 2018 at 10:41 am Seattle-based biotech startup Kineta today received a leg-up in its efforts to kill cancerous tumors using the immune system. Kineta announced an agreement with drug giant Pfizer that includes $15 million in… Read More